{
    "id": "629666fe-b8a7-45f4-b7be-b68e18910715",
    "indications": {
        "text": "mycophenolate mofetil capsules ( mmf ) indicated prophylaxis organ rejection , adult pediatric recipients 3 months age older allogeneic kidney [ ( 14.1 ) ] , heart [ ( 14.2 ) ] liver transplants [ ( 14.3 ) ] , combination immunosuppressants .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adu lts kidney transplant 1 g twice daily , orally ( 2.2 ) heart transplant 1.5 g twice daily orally ( 2.3 ) liver transplant 1.5 g twice daily orally ( 2.4 ) pediatrics kidney transplant 600 mg/m 2 orally twice daily , maximum 2 g daily ( 2.2 ) heart transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 2.3 ) liver transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 2.4 ) reduce interrupt dosing event neutropenia . ( 2.5 ) full prescribing information ( fpi ) : adjustments renal impairment neutropenia ( 2.5 )",
        "doid_entities": [
            {
                "text": "neutropenia (DOID:1227)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1227"
            }
        ],
        "orphanet_entities": []
    },
    "adverseReactions": "allergic mycophenolate mofetil capsules observed ; therefore , mycophenolate mofetil capsules contraindicated patients hypersensitivity mycophenolate mofetil ( mmf ) , mycophenolic acid ( mpa ) component product .",
    "ingredients": [
        {
            "name": "MYCOPHENOLATE MOFETIL",
            "code": "9242ECW6R0",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8764"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Teva Pharmaceuticals USA, Inc.",
    "name": "Mycophenolate Mofetil",
    "effectiveTime": "20230701",
    "indications_original": "Mycophenolate mofetil capsules (MMF) are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1)], heart [see Clinical Studies (14.2)] or liver transplants [see Clinical Studies (14.3)], in combination with other immunosuppressants.",
    "contraindications_original": "ADU LTS DOSAGE Kidney Transplant 1 g twice daily, orally (2.2) Heart Transplant 1.5 g twice daily orally (2.3) Liver Transplant 1.5 g twice daily orally (2.4) PEDIATRICS Kidney Transplant 600 mg/m 2 orally twice daily, up to maximum of 2 g daily (2.2) Heart Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (2.3) Liver Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (2.4) Reduce or interrupt dosing in the event of neutropenia. ( 2.5 ) See full prescribing information (FPI) for: adjustments for renal impairment and neutropenia ( 2.5 )",
    "adverseReactions_original": "Allergic reactions to mycophenolate mofetil capsules have been observed; therefore, mycophenolate mofetil capsules are contraindicated in patients with a hypersensitivity to mycophenolate mofetil (MMF), mycophenolic acid (MPA) or any component of the drug product.",
    "drug": [
        {
            "name": "Mycophenolate Mofetil",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8764"
        }
    ]
}